PAST 38 BY 38 RECIPIENTS
Adam Yestrepsky
"The honors engineering learning community introduced me to my best friends and wife, who continue to challenge and support me to this day. EPICS gave me the opportunity to apply engineering design to toys for a children's hospital. This sparked a desire to design devices that help people which I have carried ever since. SURF and internships exposed me to the confluence of laboratory research and industry, highlighting how basic science and engineering can be applied to a clinical need. Finally, I forged close relationships with world class researchers who sparked a love of experimentation, data, and problem solving."
Adam Yestrepsky | Biomedical Engineering
Vice President of Research and Development Engineering, enableCV, Inc.
Adam Yestrepsky is a leader in the design, development, and commercialization of life-saving medical devices, and every
day, thousands of patients and surgeons around the world are either helped by or utilize these technologies. "The
magnitude of this responsibility is profound and a major reason I am continually driven to further advance the practice
of minimally invasive cardiac surgery," he said.
At Edwards Lifesciences, Yestrepsky was awarded Top Talent designation and progressed through six levels of new product
development engineering, ultimately achieving the director level within nine years. After 13 years with the company, he
was promoted to vice president of R&D Engineering at enableCV, Inc., a subsidiary of Edwards focused exclusively on
spearheading a new era of cardiovascular surgery. He oversees the development and commercial support of a suite of
minimally invasive devices that facilitate cardiac surgery through small incisions, sparing the sternum. These devices
have been shown to significantly reduce the length of hospital stays and lower the recovery burden while still providing
the gold standard in surgical procedures.
It was Purdue that exposed him to the concept of applying basic science and engineering to a clinical need and sparked
his love of experimentation, data, and problem-solving. He has been awarded eight patents for minimally invasive
surgical technologies, including an aortic occlusion device and a beating-heart mitral valve chordae replacement, and he
has been instrumental in multiple commercial product launches.